Parameter
| Biomarker | CTC | Full name | Circulating tumor cells | Molecular Type | Cellular |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Blood (CTC enrichment and enumeration techniques) | ||
| Pathobiological Mechanisms | CTCs are an independent prognostic indicator of poor survival and aggressive tumor progression in BC patients | ||||
| Clinical Availability Status | Clinical validation stage: meta-analysis confirmed prognostic value; standardized protocols needed | ||||
| Notes and Dynamics | Cell-level prognostic marker providing direct evidence for BC progression assessment | ||||